doxorubicin hydrochloride has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, N; Chen, Y; Ding, Y; Ge, W; Han, F; Hao, X; Liu, Z; Wang, M; Wang, T; Zhang, Q | 1 |
| Deng, ZX; Hong, K; Li, D; Liang, JJ; Ni, YH; Qin, KM; Yan, JJ; Yang, L; Yin, YP; Yu, WL; Zhong, YX | 1 |
2 other study(ies) available for doxorubicin hydrochloride and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Chemistry Techniques, Synthetic; Humans; Sesquiterpenes; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2019 |
Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; MCF-7 Cells; Proto-Oncogene Proteins c-akt; Rats; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2022 |